Ardea Biosciences, Inc. (RDEA) Posts Q4 Loss of $1.15; Revs Light

Ardea Biosciences, Inc. (NASDAQ: RDEA) reported Q4 EPS of ($1.15), $0.29 worse than the analyst estimate of ($0.86). Revenue for the quarter came in at $1.7 million versus the consensus estimate of $1.85 million.

For earnings history and earnings-related data on Ardea Biosciences, Inc. (RDEA) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Lockheed Martin (LMT) Tops Q1 EPS by 53c, Beats on Revenue; Offers FY24 Guidance
• NextEra Energy Partners (NEP) Tops Q1 EPS by 50c
• Freeport-McMoran (FCX) Tops Q1 EPS by 3c